Growing Adoption of Biopharmaceuticals Increases Demand for Active Pharmaceutical Ingredients Globally | UnivDatos Market Overview

NOIDA, India, September 19, 2022 /PRNewswire/ — According to a new report published by UnivDatos Markets Insights, the Active Pharmaceutical Ingredients Market was rated at $185 billion in 2020 and is expected to grow at a CAGR of over 6% over the period 2021-2027. The analysis was segmented into synthesis (biotech and synthetic), manufacturer type (commercial APIs and captive APIs), drug type (generic APIs and innovative APIs), application (communicable diseases, oncology, diabetes, cardiovascular disease (CVD) , pain management, respiratory and other diseases); Region/Country.

Click here to view the report description and table of contents

https://univdatos.com/report/active-pharmaceutical-ingredient-market/

The Active Pharmaceutical Ingredients Market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report uses several analyzes to get a clearer view of the Active Pharmaceutical Ingredients market. The Active Pharmaceutical Ingredients Market report offers a detailed analysis of the latest industry developments and market trending factors that are influencing market growth. Additionally, this statistical market research repository examines and estimates the Active Pharmaceutical Ingredients market globally and regionally.

Request sample pages

https://univdatos.com/get-a-free-sample-form-php/?product_id=20418

Market overview

The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects. Some medications contain more than one active pharmaceutical ingredient. Rising prevalence of various diseases coupled with COVID-19 pandemic is expected to drive the active pharmaceutical ingredients market. Additionally, increasing investment in research and development of targeted and specific drugs and pharmacogenetic drugs is also expected to support the growth of the market. Worldwide, the increase in chronic diseases is leading to increased demand for treatment and is having positive impacts on the drug manufacturing market. For example, Istodax, a drug registered by Celgene Co. in 2009 for cancer (cutaneous T-cell lymphoma) saw 30% growth in 2018 compared to 2010, representing $16 million in 2010 and reached $63 million in 2018.

Click here to view the report description and table of contents

https://univdatos.com/report/active-pharmaceutical-ingredient-market/

The global Active Pharmaceutical Ingredients market report is studied extensively with several aspects which would help the stakeholders to make their decisions more carefully.

  • Based on synthesis, the market is divided into biotechnology and synthetic. During the forecast period, the biotechnology segment is expected to witness significant growth. This is mainly due to the increasing focus on increasing the precision of biopharmaceutical drugs as well as increasing investment in biotechnology research which is driving the market. Additionally, these drugs also provide patient-specific treatments that increase the effectiveness of the drug with minimal side effects.
  • On the basis of manufacturing type, the market is categorized into merchant APIs and captive APIs. Among the two, captive API is expected to witness significant growth over the forecast period. This can be attributed to improved marketing strategies as well as increased connectivity associated with innovations in manufacturing. In addition, increasing public investment in pharmaceutical industries in developing countries such as India, China, Braziland Mexico are also contributing to the growth of captive APIs.
  • Based on drug type, the Active Pharmaceutical Ingredients market has been divided into Generic APIs and Innovative APIs. Among them, the innovative API market is expected to grow at a significant rate during the forecast period. Rising prevalence of new diseases and increasing demand for more targeted and effective drugs for the treatment of various chronic diseases are expected to drive the market.
  • Based on therapeutic application, the market is categorized into communicable diseases, oncology, diabetes, cardiovascular disease (CVD), pain management, respiratory disease, and others. Among them, the cardiovascular segment dominated the market in 2020 owing to the growing prevalence of cardiovascular disorders and growing awareness of the seriousness of heart diseases. However, the oncology segment is expected to grow in the foreseeable future. Sedentary lifestyle, increasing cases of alcohol and tobacco abuse and increasing pollution are some of the main factors responsible for increasing cases of chronic diseases such as cancer and diabetes around the world. Thus, the need for effective treatment and drugs is expected to drive the API market over the forecast period.

Take a look at the chapters – https://univdatos.com/report/active-pharmaceutical-ingredient-market/

Geographical segmentation of Active Pharmaceutical Ingredients market includes:

  • North America (United States, Canadaand Rest of North America)
  • Europe (Germany, UK, Spain, Italy, Franceand the rest of Europe)
  • Asia Pacific (China, Japan, India, South Koreaand the rest of Asia Pacific)
  • Rest of the world

For a better understanding of the market adoption of the Active Pharmaceutical Ingredients industry, the market is analyzed based on its global presence in countries such as North America (United States, Canadaand the rest of North America), Europe (Germany, France, Italy, Spain, UK and rest of Europe), Asia Pacific (China, Japan, India, South Korea, and Rest of APAC) and Rest of the world. During the forecast period, North America is expected to experience the highest CAGR during the forecast period. Moreover, the increase in the geriatric population coupled with the growing number of patients with chronic diseases provides immense opportunities for market players to develop APIs. Additionally, increasing investment in biotechnology and biopharmaceutical industry along with increasing healthcare expenditure in the region are other major factors driving the North America API market.

Key players targeting the market include

  • Merck & Co.
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Cipla inc.
  • Teva Pharmaceutical Industries Ltd.
  • Albemarle Society
  • Viatris inc.
  • Aurobindo Pharmacy
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.

Competitive landscape

The degree of competition between major global companies has been worked out by analyzing several key players operating across the globe. The specialized team of research analysts sheds light on various traits such as global market competition, market share, latest industry advancements, innovative product launches, partnerships, mergers or acquisitions by leading companies in the Active Pharmaceutical Ingredients Market. Major players have been analyzed using research methodologies to get an overview of the global competition.

Key questions answered through this analytical market research report include:

  • What are the latest trends, patterns, and technological advancements in the Active Pharmaceutical Ingredients market?
  • What factors are influencing the Active Pharmaceutical Ingredients market over the forecast period?
  • What are the global challenges, threats and risks in the Active Pharmaceutical Ingredients market?
  • What factors are driving and restraining the Active Pharmaceutical Ingredients Market?
  • Which are the demanding global regions of the Active Pharmaceutical Ingredients Market?
  • What will be the size of the global market in the coming years?
  • What are the crucial market acquisition strategies and policies applied by global companies?

We understand the requirements of different businesses, regions and countries, we offer customized reports as per your business nature and geography requirements. Please let us know if you have any custom requirements.

Browse other related research reports from UnivDatos Market Insights

Active Pharmaceutical Ingredients Market Report cover

Report attributee

Details

base year

2020

Forecast period

2021-2027

Growth dynamics

Accelerate at a CAGR of over 6%

Market size 2020

$185 billion

Regional analysis

North America, Europe, APAC, Rest of the World

Major contributing region

North America to dominate the Active Pharmaceutical Ingredients Market

Main countries covered

United States, Canada, Germany, United Kingdom, Spain, Italy, France, China, Japan, India and South Korea

Profiled companies

Merck & Co., Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Cipla, Inc., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd. , and Dr Reddy’s Laboratories Ltd

Report scope

Market trends, drivers and restraints; Revenue estimation and forecasting; segmentation analysis; impact of COVID-19; Analysis of supply and demand; VScompetitive landscape; Company profiling

Segments Covered

By synthesis; By type of manufacturer; By type of drug; By application; By region/country

About UnivDatos Market Insights (UMI)

UnivDatos Market Insights (UMI) is a passionate market research company and a subsidiary of Universal Data Solutions. We believe in providing information through market intelligence reports, custom business research and primary research. Our research studies are spread across topics across the globe, we cover markets in over 100 countries using smart research techniques and agile methodologies. We offer in-depth studies, detailed analysis and custom reports that help shape winning business strategies for our clients.

Contact

UnivDatos Market Overview
Ankita Gupta
Director of Operations
Phone: +91-7838604911
E-mail: [email protected]
Website: https://univdatos.com/

Logo: https://mma.prnewswire.com/media/1225049/UnivDatos_Logo.jpg

SOURCE UnivDatos Market Insights Pvt. ltd.